Faculty
Oncology Division
Jason M. Held, PhD
Assistant Professor
Department of Medicine
Oncology Division
Molecular Oncology
Research Interests
- Redox signaling
- Proteomics
- Breast cancer, lung cancer, sarcoma
- Protein post-translational modifications
Contact
- 314-747-9738 (office)
- 314-747-0571 (lab)
- 314-747-9320 (fax)
- jheld@wustl.edu
- Division of Oncology
Mail Stop 8076-0041-03
Washington University
660 South Euclid Avenue
St. Louis, MO 63110 - Room 3305, Couch Biomedical Research Building (lab)
- Lab website
- DBBS profile
Biosketch
| Education | |
|---|---|
| 1997-2001 | BS in Biology, Duke University, Durham, NC |
| 2001-2006 | PhD in Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, CA |
| Post-Graduate Training | |
| 2006-2008 | Postdoctoral Fellow, The Buck Institute for Research on Aging, Novato, CA |
| Academic Positions & Employment | |
| 2008-2013 | Staff Scientist, The Buck Institute for Research on Aging, Novato, CA |
| 2013-present | Assistant Professor, Department of Medicine, Washington University, St. Louis, MO |
| 2013-present | Assistant Professor, Department of Anesthesiology, Washington University, St. Louis, MO |
| Honors & Awards | |
| 2000 | Howard Hughes Undergraduate Neuroscience Fellow, Duke University |
| 2001 | Achievement Rewards for College Scientists (ARCS) Foundation Scholar |
| 2004 | American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship |
| 2013 | AB SCIEX Young Investigator Award |
| Editorial Responsibilities | |
| Forum Editor (single issue), Antioxidant and Redox Signaling journal | |
| Ad hoc Editor, PLoS Computational Biology | |
| National Scientific Panels | |
| Panelist, Society for Redox Biology and Medicine's "In the Land of 'Omics" | |
| Ad hoc Reviewer, Congressionally-directed Medical Research Program (CDMRP) Lung Cancer Research Program Grant Review Panel | |
| Ad hoc Reviewer, National Institute of Health’s Tumor Cell Biology Study Section | |
| Ad hoc Reviewer, National Institute of Health’s R15 Study Section | |
| Ad hoc Reviewer, National Cancer Institute’s IMAT Program, R21 Study Section | |
| Ad hoc Reviewer, National Institute of Health’s Clinical and Translational R21 and Omnibus R03 Study Section | |
| Ad hoc Reviewer, National Institute of Health Director's New Innovator Award Program (DP2) | |
| Professional Societies | |
| 2006-present | American Society for Mass Spectrometry |
| 2017-present | Society for Free Radical Biology in Medicine |
